Contract VA25517J0056
New York Blood Center, Inc. · Department Of Veterans Affairs · October 5, 2016
New York Blood Center, Inc. was awarded a federal contract by Department Of Veterans Affairs on October 5, 2016 for $683,000 of work in biological product (except diagnostic) manufacturing. Performance is in Kansas City, MO. This is a task or delivery order issued under parent IDIQ VA25516D0217. The contract has been modified 7 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 22, 2021.
Contract details
- PIID
- VA25517J0056
- Parent IDIQ
- VA25516D0217
- Award type
- Delivery Order
- Pricing
- Fixed Price With Economic Price Adjustment
- Competition
- Full And Open Competition
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Kansas City, MO
- First action
- October 5, 2016
- Latest action
- December 22, 2021
Description
BLOOD AND BLOOD PRODUCTS FOR KANSAS CITY, LEAVENWORTH AND TOPEKA VA MEDICAL CENTERS.
Modification timeline
-
December 22, 2021Mod P00007$-2.4K
-
May 3, 2021Mod P00006$-623
-
January 30, 2018Mod P00005$-57.2K
-
August 17, 2017Mod P00004$18.3K
-
June 15, 2017Mod P00003$0
-
March 21, 2017Mod P00002$0
-
November 15, 2016Mod P00001$0
-
October 5, 2016Base award$725.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| American National Red Cross, The | Department Of Veterans Affairs | March 25, 2026 | $1.65M |
| New York Blood Center, Inc. | Department Of Veterans Affairs | March 18, 2026 | $670.0K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $137.6K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $102.8K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $124.6K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $0 |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract VA25517J0056?
Contract VA25517J0056 is a federal contract awarded to New York Blood Center, Inc. by Department Of Veterans Affairs on October 5, 2016 for $683,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 7 times since the base award.
Who won contract VA25517J0056?
New York Blood Center, Inc. won contract VA25517J0056 from Department Of Veterans Affairs.
How much is contract VA25517J0056 worth?
Contract VA25517J0056 has obligated $683,000 to date, with a total potential value of $686,000 if all options are exercised.